National Bank Of Canada Revolution Medicines, Inc. Transaction History

National Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$20.76 - $30.09 $109,342 - $158,484	5,267 Added 20.64%	30,783 $666,000
Q2 2022 Jul 28, 2022	BUY	$14.54 - $27.17 $55,673 - $104,033	3,829 Added 17.66%	25,516 $533,000
Q1 2022 May 05, 2022	BUY	$17.31 - $26.4 $375,401 - $572,536	21,687 New	21,687 $512,000

302

189M

186K

672K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.38B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.